Jiachen Xu
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The E3 Ubiquitin Ligase RNF123 Mediates Pathological Cardiac Hypertrophy by Ubiquitinating PRDX1 and Upregulating Oxidative Stress in Cardiomyocytes.
Journal: Acta physiologica (Oxford, England)
Published: July 02, 2025
Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21.
Journal: Theranostics
Published: June 06, 2024
Deubiquitinase USP25 Alleviates Obesity-Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation.
Journal: JACC. Basic to translational science
Published: April 09, 2024
Macrophage OTUD1-CARD9 axis drives isoproterenol-induced inflammatory heart remodelling.
Journal: Clinical and translational medicine
Published: February 20, 2024
Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 04, 2023
OTUD1 promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytes.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 02, 2023
20(S)-ginsenoside Rh2 inhibits angiotensin-2 mediated cardiac remodeling and inflammation associated with suppression of the JNK/AP-1 pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 29, 2023
JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes.
Journal: Cellular and molecular life sciences : CMLS
Published: July 05, 2023
Ginsenoside Rg5 alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the JNK/AP-1 pathway.
Journal: International immunopharmacology
Published: April 20, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026